The lethality of Ku86 (XRCC5) loss-of-function mutations in human cells is independent of p53 (TP53)

Radiation Research

Volumn 167, Issue 1, 2007, Pages 66-79

  Ghosh, Goutam ^a   Li, Gang ^a,c   Myung, Kyungjae ^b   Hendrickson, Eric A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN; PROTEIN KU86; PROTEIN P53; PROTEIN XRCC5; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIVISION; CONTROLLED STUDY; DNA DAMAGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TELOMERE; WILD TYPE;

CELL PROLIFERATION; DNA DAMAGE; DNA HELICASES; DNA, COMPLEMENTARY; DNA-ACTIVATED PROTEIN KINASE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HETEROZYGOTE; HISTONES; HUMANS; MODELS, GENETIC; MUTATION; NUCLEAR PROTEINS; RADIATION TOLERANCE; RADIATION, IONIZING; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 33846304689     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0692.1     Document Type: Article

References (62)

1. J. H. Hoeijmakers, Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
2. C. Wyman, D. Ristic and R. Kanaar, Homologous recombination-mediated double-strand break repair. DNA Repair 3, 827-833 (2004).
3. M. R. Lieber, Y. Ma, U. Pannicke and K. Schwarz, Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 4, 712-720 (2003).
4. P. Ahnesorg, P. Smith and S. P. Jackson, XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124, 301-313 (2006).
5. D. Buck, L. Malivert, R. de Chasseval, A. Barraud, M. C. Fondaneche, O. Sanal, A. Plebani, J. L. Stephan, M. Hufnagel and P. Revy, Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124, 287-299 (2006).
6. E. Riballo, S. E. Critchlow, S-H. Teo, A. J. Doherty, A. Priestley, B. Broughton, B. Kysela, H. Beamish, N. Plowman and P. A. Jeggo, Identification of a defect in DNA ligase IV in a radiosensitive leukemia patient. Curr. Biol. 9, 699-702 (1999).
7. D. Moshous, I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo, F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand and J. P. de Villartay, Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105, 177-186 (2001).
8. M. O'Driscoll, K. M. Cerosaletti, P. M. Girard, Y. Dai, M. Stumm, B. Kysela, B. Hirsch, A. Gennery, S. E. Palmer and P. Concannon, DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8, 1175-1185 (2001).
9. E. A. Hendrickson, J. L. Huffman and J. A. Tainer, DNA Damage Recognition (W. Seide, Y. W. Kow and P. Doetsch, Eds.), pp. 629-684. Taylor & Francis, New York, 2006.
10. P. Hande, P. Slijepcevic, A. Silver, S. Bouffler, P. van Buul, P. Bryant and P. Lansdorp, Elongated telomeres in scid mice. Genomics 56, 221-223 (1999).
11. S. Espejel, S. Franco, A. Sgura, D. Gae, S. M. Bailey, G. E. Taccioli and M. A. Blasco, Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J. 21, 6275-6287 (2002).
12. S. M. Bailey, J. Meyne, D. J. Chen, A. Kurimasa, G. C. Li, B. E. Lehnert and E. H. Goodwin, DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc. Natl. Acad. Sci. USA 96, 14899-14904 (1999).
13. D. Gilley, H. Tanaka, M. P. Hande, A. Kurimasa, G. C. Li, M. Oshimura and D. J. Chen, DNA-PKcs is critical for telomere capping. Proc. Natl. Acad. Sci. USA 98, 15084-15088 (2001).
14. F. A. Goytisolo, E. Samper, S. Edmonson, G. E. Taccioli and M. A. Blasco, The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21, 3642-3651 (2001).
15. M. Z. Zdzienicka, Mammalian mutants defective in the response to ionizing radiation-induced DNA damage. Mutat. Res. 336, 203-213 (1995).
16. Y. Gu, S. Jin, Y. Gao, D. T. Weaver and F. W. Alt, Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc. Natl. Acad. Sci. USA 94, 8076-8081 (1997).
17. A. Nussenzweig, C. Chen, V. da Costa Soares, M. Sanchez, K. Sokol, M. C. Nussenzweig and G. C. Li, Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382, 551-555 (1996).
18. C. Zhu, M. A. Bogue, D-S. Lim, P. Hasty and D. B. Roth, Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-389 (1996).
19. H. Ouyang, A. Nussenzweig, A. Kurimasa, V. C. Soares, X. Li, C. Cordon-Cardo, W. H. Li, N. Cheong, M. Nussenzweig and G. Li, Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J. Exp. Med. 15, 921-929 (1997).
20. C. Jhappan, H. C. Morse, R. D. Fleischmann, M. M. Gottesman and G. Merlino, DNA-PKcs: A T-cell tumor suppressor encoded at the mouse scid locus. Nat. Genet. 17, 483-486 (1997).
21. A. Nussenzweig, K. Sokol, P. Burgman, L. Li and G. C. Li, Hypersensitivity of Ku80-deficient cell lines and mice to DNA damage: The effects of ionizing radiation on growth, survival and development. Proc. Natl. Acad. Sci. USA 94, 13588-13593 (1997).
22. G. Li, C. Nelsen and E. A. Hendrickson, Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. USA 99, 832-837 (2002).
23. H. Vogel, D-S. Lim, G. Karsenty, M. Finegold and P. Hasty, Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl. Acad. Sci. USA 96, 10770-10775 (1999).
24. Z. E. Karanjawala, U. Grawunder, C. L. Hsieh and M. R. Lieber, The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9, 1501-1504 (1999).
25. M. J. Difilippantonio, J. Zhu, H. T. Chen, E. Meffre, M. C. Nussenzweig, E. E. Max, T. Ried and A. Nussenzweig, DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404, 510-514 (2000).
26. F. d' Adda di Fagagna, M. P. Hande, W-M. Tong, D. B. Roth, P. M. Lansdorp, Z-Q. Wang and S. P. Jackson, Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11, 1192-1196 (2001).
27. K. Myung, G. Ghosh, F. J. Fattah, G. Li, H. Kim, A. Dutia, E. Pak, S. Smith and E. A. Hendrickson, Regulation of telomere length and suppression of genomic instability in human somatic cells by Ku86. Mol. Cell. Biol. 24, 5050-5059 (2004).
28. E. Samper, F. A. Goytisolo, P. Slijepcevic, P. P. W. van Buul and M. A. Blasco, Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244-252 (2000).
29. V. Smider, W K. Rathmell, M. R. Lieber and G. Chu, Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 266, 288-291 (1994).
30. A. Errami, V. Smider, W. K. Rathmell, D. M. He, E. A. Hendrickson, M. Z. Zdzienicka and G. Chu, Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Mol. Cell. Biol. 16, 1519-1526 (1996).
31. D. S. Lim, H. Vogel, D. M. Willerford, A. T. Sands, K. A. Platt and P. Hasty, Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell. Biol. 20, 3772-3780 (2000).
32. Z. Sadji, M. Le Romancer, M. J. Lewin and F. Reyl-Desmars, Human colon carcinoma cell-line HCT116 transfected by antisense cDNA as a tool to study the Ku86 involvement in cell proliferation. Cell. Signal. 12, 745-750 (2000).
33. E. Marangoni, M. Le Romancer, N. Foray, C. Muller, S. Douc-Rasy, S. Vaganay, B. Abdulkarim, M. Barrois, P. Calsou and J. Bourhis, Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts. Cancer Gene Ther. 7, 339-346 (2000).
34. I. Jaco, P. Munoz and M. A. Blasco, Role of human Ku86 in telomere length maintenance and telomere capping. Cancer Res. 64, 7271-7278 (2004).
35. K. Uegaki, N. Adachi, S. So, S. Iiizumi and H. Koyama, Heterozygous inactivation of human Ku70/Ku86 heterodimer does not affect cell growth, double-strand break repair, or genome integrity. DNA Repair 5, 303-311 (2006).
36. S. Omori, Y. Takiguchi, A. Suda, T. Sugimoto, H. Miyazawa, N. Tanabe, K. Tatsumi, H. Kimura, P. E. Pardington and T. Kuriyama, Suppression of a DNA double-strand break repair gene, Ku70, increases radio- and chemosensitivity in a human lung carcinoma cell line. DNA Repair 1, 299-310 (2002).
37. D. W. Meek, The p53 response to DNA damage. DNA Repair 3, 1049-1056 (2004).
38. C. Barlow, M. Liyange, P. B. Moens, C-X. Deng, T. Ried and A. Wynshaw-Boris, Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat. Genet. 17, 462-466 (1997).
39. R. Hakem, J. L. de la Pompa, A. Elia, J. Potter and T. W. Mak, Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16, 298-302 (1997).
40. S. N. Jones, A. E. Roe, L. A. Donehower and A. Bradley, Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208 (1995).
41. Y. Gao, D. O. Ferguson, W. Xie, J. P. Manis, J. Sekiguchi, K. M. Frank, J. Chaudhuri, J. Horner, R. A. DePinho and F. W. Alt, Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404, 897-900 (2000).
42. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J. P. Brown, J. M. Sedivy, K. W. Kinzler and B. Vogelstein, Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (1998).
43. N. V. Boubnov, K. T. Hall, Z. Wills, S. E. Lee, D. M. He, D. M. Benjamin, C. R. Pulaski, H. Band, W. Reeves and D. T. Weaver, Complementation of the ionizing radiation sensitivity, DNA end binding, and V(D)J recombination defects of double-strand break repair mutants by the p86 Ku autoantigen. Proc. Natl. Acad. Sci. USA 92, 890-894 (1995).
44. Z. Han, C. Johnston, W. H. Reeves, T. Carter, J. H. Wyche and E. A. Hendrickson, Characterization of a Ku86 variant protein that results in altered DNA binding and diminished DNA-dependent protein kinase activity. J. Biol. Chem. 271, 14098-14104 (1996).
45. O. Hammarsten and G. Chu, DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc. Natl. Acad. Sci. USA 95, 525-530 (1998).
46. R. McElligott and R. J. Wellinger, The terminal DNA structure of mammalian chromosomes. EMBO J. 16, 3705-3714 (1997).
47. B. van Steensel, A. Smogorzewska and T. de Lange, TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401-413 (1998).
48. D. M. He, S. E. Lee and E. A. Hendrickson, Restoration of x-ray and etoposide resistance, Ku-end binding activity and V(D)J recombination to the Chinese hamster sxi-3 mutant by a hamster Ku86 cDNA. Mutat. Res. 363, 43-56 (1996).
49. W. K. Rathmell and G. Chu, Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc. Natl. Acad. Sci. USA 91, 7623-7627 (1994).
50. N. J. Finnie, T. M. Gottlieb, T. Blunt, P. A. Jeggo and S. P. Jackson, DNA-dependent protein kinase activity is absent in xrs-6 cells: Implications for site-specific recombination and DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 92, 320-324 (1995).
51. S. P. Lees-Miller, R. Godbout, D. W. Chan, M. Weinfeld, R. S. Day III, G. M. Barron and J. Allalunis-Turner, Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267, 1183-1185 (1995).
52. N. A. Balatsos and E. P. Rogakou, DNA Damage Recognition (W. Seide, Y. W. Kow and P. Doetsch, Eds.), pp. 723-735. Taylor & Francis, New York, 2006.
53. W. R. Brown, P. J. MacKinnon, A. Villasante, N. Spurr, V. J. Buckle and M. J. Dobson, Structure and polymorphism of human telomere-associated DNA. Cell 63, 119-132 (1990).
54. R. Notaro, A. Cimmino, D. Tabarini, B. Rotoli and L. Luzzatto, In vivo telomere dynamics of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 94, 13782-13785 (1997).
55. L. Masramon, M. Ribas, P. Cifuentes, R. Arribas, F. Garcia, J. Egozcue, M. A. Peinado and R. Miro, Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting. Cancer Genet. Cytogenet. 121, 17-21 (2000).
56. W. M. Abdel-Rahman, K. Katsura, W. Rens, P. A. Gorman, D. Sheer, D. Bicknell, W. F. Bodmer, M. J. Arenas, A. H. Wyllie and P. A. Edwards, Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc. Natl. Acad. Sci. USA 98, 2538-2543 (2001).
57. L. D. Attardi, The role of p53-mediated apoptosis as a crucial antitumor response to genomic instability: Lessons from mouse models. Mutat. Res. 569, 145-157 (2005).
58. U. Grawunder, D. Zimmer, S. Fugmann, K. Schwarz and M. R. Lieber, DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol. Cell 2, 477-484 (1998).
59. N. Adachi, S. So, S. Iiizumi, Y. Nomura, K. Murai, C. Yamakawa, K. Miyagawa and H. Koyama, The human pre-B cell line Nalm-6 is highly proficient in gene targeting by homologous recombination. DNA Cell Biol. 25, 19-24 (2006).
60. R. R. Reddel, T. M. Bryan, L. M. Colgin, K. T. Perrem and T. R. Yeager, Alternative lengthening of telomeres in human cells. Radiat. Res. 155, 194-200 (2001).
61. M. T. Hemann, M. A. Strong, L. Y. Hao and C. W. Greider, The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77 (2001).
62. T. de Lange, Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-2110 (2005).